| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TScan Therapeutics, Inc. | Chief Business Officer | Stock Option (Right to Buy) | 30,000 | 25 Jul 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TCRX | TScan Therapeutics, Inc. | 25 Jul 2022 | 1 | $0 | 4 | Chief Business Officer | 27 Jul 2022, 16:30 |
| TCRX | TScan Therapeutics, Inc. | 18 Jan 2022 | 1 | $0 | 4 | Chief Business Officer | 20 Jan 2022, 15:29 |
| TCRX | TScan Therapeutics, Inc. | 27 Aug 2021 | 1 | +$22,708 | 4 | Chief Business Officer | 31 Aug 2021, 17:56 |
| TCRX | TScan Therapeutics, Inc. | 15 Jul 2021 | 0 | $0 | 3 | Chief Business Officer | 15 Jul 2021, 18:24 |